National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
Introduction The previous data concerning the prevalence of idiopathic pulmonary fibrosis (IPF) and the frequency of antifibrotic drug use in Finland were based on research registries and medical records whereas nationwide data on the number of patients with IPF in specialised care and those on anti...
Κύριοι συγγραφείς: | Riitta Kaarteenaho, Johanna Salonen, Minna Purokivi, Ulla Hodgson |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
BMJ Publishing Group
2022-09-01
|
Σειρά: | BMJ Open Respiratory Research |
Διαθέσιμο Online: | https://bmjopenrespres.bmj.com/content/9/1/e001363.full |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Are physicians in primary health care able to recognize pulmonary fibrosis?
ανά: Minna Purokivi, κ.ά.
Έκδοση: (2017-01-01) -
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
ανά: Jaana Kaunisto, κ.ά.
Έκδοση: (2019-07-01) -
Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings
ανά: Johanna Salonen, κ.ά.
Έκδοση: (2023-01-01) -
Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
ανά: Miia Kärkkäinen, κ.ά.
Έκδοση: (2018-05-01) -
Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study
ανά: Eeva Saari, κ.ά.
Έκδοση: (2023-05-01)